Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Md. Fazal Karim x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Treatment of chronic hepatitis B has changed much since the introduction of interferon. Nucleosides have come to replace interferon in some situations like decompensated states. However, there is no clear cut guideline in many fields. Even end of treatment response is low in conventional treatments. This study describes a few scenarios where difficulties were faced. Unresolved questions in the management of chronic hepatitis B involve ‘who to treat, when to treat, how to treat?’ These should be clearly addressed.

Restricted access